Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2010

May 19, 2010

31523_dirs_2010-05-19_4958ac40-0bb2-45bc-ac86-03d7e945dd4c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-05-10

Reporting Person: Valenzano Ken (VP, Pharmacology & Biology)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1708 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (right to buy) $0.64 2015-06-09 Common Stock (2793) Direct
Stock Options (right to buy) $5.33 2015-10-20 Common Stock (2000) Direct
Stock Options (right to buy) $5.33 2016-02-28 Common Stock (9500) Direct
Stock Options (right to buy) $13.43 2017-04-25 Common Stock (13334) Direct
Stock Options (right to buy) $10.21 2018-02-05 Common Stock (12500) Direct
Stock Options (right to buy) $10.36 2019-02-03 Common Stock (12000) Direct
Stock Options (right to buy) $4.16 2019-11-16 Common Stock (30000) Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on April 25, 2008. The remaining options vest and become exercisable in a series of thirty-six equal monthly installments, beginning on May 1, 2008.

F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on February 5, 2009. The remaining options vest and become exercisable in a series of thirty-six equal monthly installments, beginning on March 1, 2009.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on February 3, 2010. The remaining options vest and become exercisable in a series of thirty-six equal monthly installments, beginning on March 1, 2010.

F4: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, will vest on November 16, 2010. The remaining options will vest and become exercisable in a series of thirty-six equal monthly installments, beginning on December 1, 2010.